Latest Manufacturing News

ITM Isotope Technologies Munich SE and Radiopharm Theranostics have entered a strategic supply agreement for the critical radioisotope Lutetium-177, underpinning Radiopharm’s clinical development of targeted cancer therapies.

Cynata Therapeutics confirms that the recent FDA orphan-drug exclusivity granted to Ryoncil® will not block approval of its CYP-001 therapy, highlighting key differences in drug composition and patient indications.

Simble Solutions Limited reported solid operational progress in 2024 and early 2025, highlighting new partnerships, product integrations, and a strategic push into renewable energy developments.

Larvotto Resources has announced an initial tungsten mineral resource at its Hillgrove Project, revealing a significant by-product opportunity alongside gold and antimony. This development could diversify revenue streams and enhance project economics amid rising tungsten prices.

HITIQ Limited has announced a non-renounceable entitlement offer to raise up to $2.92 million, supported by partial underwriting from GBA Capital and accompanied by new options issuance. The capital raise aims to fund expansion, product development, and operational growth.

Chimeric Therapeutics reports encouraging interim results from its ADVENT-AML Phase 1B trial, with two of three newly diagnosed AML patients achieving remission using their novel CORE-NK cell therapy combined with standard treatment.

Epsilon Healthcare has launched a $1 million loan note issue aimed at supporting its working capital and diversification efforts, with a 10% interest rate and potential share conversion.

Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.

AKORA Resources has appointed Peter Bird as its new Managing Director and CEO, marking a strategic leadership change aimed at advancing the Bekisopa Iron Ore Project and securing critical funding and partnerships.

NRW Holdings faces a significant threat to its $113.3 million secured debt after the South Australian Government proposed legislation that could invalidate key lease agreements underpinning its security interests in Whyalla Ports.

Orora Limited announces a leadership transition in its Global Glass division, with Emmanuel Ladent set to succeed Jean Marc Arrambourg as President by year-end 2025.

Euro Manganese Inc. reported a net loss of CAD 9.174 million for the half-year ending March 31, 2025, while making significant progress on its Chvaletice Manganese Project, including securing key permits and strategic status under EU and Czech frameworks. The company’s development hinges on completing a crucial private placement and share purchase plan to sustain operations.